SARAJEVO (Bosnia and Herzegovina), June 26 (SeeNews) – The Sarajevo Stock Exchange (SASE) on Thursday said it suspended trade in the shares of Bosnia’s biggest pharmaceutical firm, Bosnalijek, because the company has failed to inform the bourse about a planned bonus share issue in due time.